Adenoviral Delivery of CRISPR/Cas9 Aims to Expand Genome Editing to Primary Cells
Type
Blog Post
Published
Dec. 10, 2020, 1 p.m.
...genome, removing the risk of oncogenicity or genotoxicity seen with other vectors (Lukashev et al., 2016...